Advertisements
Year

Gerritsen, Winald R.

Radboud University Medical Center, Netherlands

2024 Rank: 194526

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Immunology

Rank in SubField 1: 6453 out of 334837 Researchers

Data For The Year: 2024
Metrics Self-Citations Excluded All
Rank Based on Composite Score194526224593
Total Cites14721602
H-index1717
Hm-index33
Number of Single Authored Papers44
Total Cites to Single Authored Papers22
Number of Single+First Authored Papers1111
Total Cites to Single+First Authored Papers44
Number of Single+First+Last Authored Papers6464
Total Cites to Single+First+Last Authored Papers241253
Composite Score22
Number of Distinct Citing Papers11831269
Ratio of Total Citations to Distinct Citing Papers 1.24 1.26
Self-Citation Percentage
8.11%
Found an error in your data? Contact us with your profile link. Contact Us →

Gerritsen, Winald R.

Radboud University Medical Center, Netherlands

2022 Rank: 140555

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Immunology

Rank in SubField 1: 5295 out of 293195 Researchers

Data For The Year: 2022
Metrics Self-Citations Excluded All
Rank Based on Composite Score140555151085
Total Cites15601705
H-index1717
Hm-index33
Number of Single Authored Papers44
Total Cites to Single Authored Papers44
Number of Single+First Authored Papers1111
Total Cites to Single+First Authored Papers66
Number of Single+First+Last Authored Papers6363
Total Cites to Single+First+Last Authored Papers317339
Composite Score22
Number of Distinct Citing Papers12761379
Ratio of Total Citations to Distinct Citing Papers 1.22 1.24
Self-Citation Percentage
8.50%
Found an error in your data? Contact us with your profile link. Contact Us →
Advertisements

Partner with TOPSCINET

Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.

Advertisements